Annovis Bio, Inc. announced that its stockholders have approved an amendment to the company's Certificate of Incorporation, effectively doubling the number of authorized shares of its common stock. The amendment was approved at a Special Meeting of Stockholders on November 3, 2026, and was filed with the State of Delaware on November 4, 2026.
Key Details
- Authorized Share Increase: The number of authorized shares of Common Stock has been increased from 70,000,000 to 140,000,000.
- Voting Results: The proposal was approved with approximately 85.6% of votes cast in favor at the Special Meeting.
- Additional Approval: Stockholders also ratified an amendment to the company's 2019 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan.